Medicare Enrolled

Dr. Naila Goldenberg, MD

Internal Medicine · Mason, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
969 READING RD STE N, Mason, OH 45040
5136041004
In practice since 2006 (20 years)
NPI: 1396796330 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goldenberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goldenberg? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goldenberg

Dr. Naila Goldenberg is an internal medicine specialist in Mason, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goldenberg performed 406 Medicare services across 236 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goldenberg received a total of $45,749 from 73 pharmaceutical and/or device companies across 1529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goldenberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 406 Medicare services $45,749 industry payments

Medicare Practice Summary

Medicare Utilization ↗
406
Medicare services
Bottom 39% in OH for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
236
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~20 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
263 $77 $209
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
59 $117 $282
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
46 $22 $87
New patient office visit, complex (60-74 min) 24 $144 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $54 $142
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$45,749
Total received (2018-2024)
Avg $6,536/year across 7 years
Top 3% in OH for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,529
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,014 (50.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,305 (48.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$429 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,361
2023
$3,442
2022
$2,530
2021
$3,904
2020
$3,208
2019
$17,158
2018
$12,146

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$398
Amgen Inc.
$337
Lilly USA, LLC
$328
ABBVIE INC.
$261
Boehringer Ingelheim Pharmaceuticals, Inc.
$238
BETA BIONICS, INC.
$231
Bayer Healthcare Pharmaceuticals Inc.
$179
IBSA Pharma Inc.
$153
AIMMUNE THERAPEUTICS, INC.
$139
Dexcom, Inc.
$114
Alexion Pharmaceuticals, Inc.
$114
SANOFI-AVENTIS U.S. LLC
$111
Tandem Diabetes Care, Inc.
$105
Medtronic, Inc.
$97
Mannkind Corporation
$67
Ascendis Pharma Inc
$62
Insulet Corporation
$46
Ultragenyx Pharmaceutical Inc.
$41
VIVUS LLC
$38
Phathom Pharmaceuticals, Inc.
$35
Kyowa Kirin, Inc.
$32
Xeris Pharmaceuticals, Inc.
$29
Ascensia Diabetes Care Us Inc.
$20
Eisai Inc.
$19
PFIZER INC.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Neurocrine Biosciences, Inc.
$17
Novartis Pharmaceuticals Corporation
$17
Amphastar Pharmaceuticals, Inc.
$17
SHIELD THERAPEUTICS INC
$16
Esperion Therapeutics, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$16
Verity Pharmaceuticals Inc.
$15
Amneal Pharmaceuticals LLC
$15
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$9,635
Regeneron Healthcare Solutions, Inc.
$7,992
AstraZeneca Pharmaceuticals LP
$5,508
Novo Nordisk Inc
$2,415
Corcept Therapeutics
$2,298
Lilly USA, LLC
$2,163
Amgen Inc.
$2,058
Amarin Pharma Inc.
$1,921
ABBVIE INC.
$630
Mannkind Corporation
$616
AbbVie, Inc.
$590
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$590
Dexcom, Inc.
$550
Insulet Corporation
$547
MannKind Corporation
$505
Xeris Pharmaceuticals, Inc.
$504
Medtronic MiniMed, Inc.
$490
Boehringer Ingelheim Pharmaceuticals, Inc.
$482
Bayer Healthcare Pharmaceuticals Inc.
$362
Alexion Pharmaceuticals, Inc.
$345
Janssen Pharmaceuticals, Inc
$344
Medtronic, Inc.
$339
AbbVie Inc.
$320
Antares Pharma, Inc.
$297
IBSA Pharma Inc.
$284
Novartis Pharmaceuticals Corporation
$265
Horizon Therapeutics plc
$249
Tandem Diabetes Care, Inc.
$235
BETA BIONICS, INC.
$231
Ascendis Pharma Inc
$209
Kowa Pharmaceuticals America, Inc.
$206
Shire North American Group Inc
$187
NESTLE HEALTHCARE NUTRITION INC.
$157
Clarus Therapeutics Inc.
$156
Nestle HealthCare Nutrition Inc.
$154
PFIZER INC.
$153
AIMMUNE THERAPEUTICS, INC.
$139
Aegerion Pharmaceuticals, Inc.
$128
Esperion Therapeutics, Inc.
$117
Regeneron Pharmaceuticals, Inc.
$114
ARALEZ PHARMACEUTICALS US INC.
$112
Radius Health, Inc.
$107
Amneal Pharmaceuticals LLC
$105
LifeScan, Inc.
$92
Ultragenyx Pharmaceutical Inc.
$87
Merck Sharp & Dohme Corporation
$73
Endo Pharmaceuticals Inc.
$56
Phathom Pharmaceuticals, Inc.
$51
Abbott Laboratories
$50
Ascensia Diabetes Care Us Inc.
$49
VIVUS LLC
$38
Valeritas, Inc.
$36
Gemini Laboratories, LLC
$33
Kyowa Kirin, Inc.
$32
Tolmar, Inc.
$28
RECORDATI_RARE_DISEASES_INC.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$25
Orexigen Therapeutics, Inc.
$24
Merck Sharp & Dohme LLC
$24
Eisai Inc.
$19
Currax Pharmaceuticals LLC
$19
Amryt Pharma Holdings Ltd
$18
Neurocrine Biosciences, Inc.
$17
Amphastar Pharmaceuticals, Inc.
$17
SHIELD THERAPEUTICS INC
$16
Verity Pharmaceuticals Inc.
$15
LIFESCAN, INC.
$15
DEXCOM, INC.
$15
VIVUS, Inc.
$14
Zealand Pharma US, Inc.
$13
Nalpropion Pharmaceuticals LLC
$12
Lupin Inc.
$11
Medicure Pharma Inc.
$10
Top 3 companies account for 50.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · ANTARA · Aimovig · Amitiza · Androgel · BAQSIMI · BASAGLAR · BOTOX · BYDUREON · CONTRAVE · CREON · CYCLOSET · Corlanor · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · EVKEEZA · FARXIGA · FORTEO · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · JUXTAPID · Juxtapid · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LICART · LINZESS · Leqembi · Levemir · Livalo · MINIMED 770G · MINIMED 780G · MOTEGRITY · MOUNJARO · MYALEPT · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PANCREAZE · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · QULIPTA · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SOTAGLIFLOZIN · STEGLATRO · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · ZONTIVITY · ZYPITAMAG (pitavastatin) · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for internal medicine in OH.

Looking for an internal medicine specialist in Mason?
Compare internal medicine physicians in the Mason area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,200
Per 100K population
487.1
County median income
$107,843
Nearest hospital
MERCY HEALTH KINGS MILLS HOSPITAL LLC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goldenberg is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Goldenberg experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Goldenberg performed 263 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goldenberg receive payments from pharmaceutical companies?
Yes. Dr. Goldenberg received a total of $45,749 from 73 companies across 1,529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goldenberg's costs compare to other internal medicine physicians in Mason?
Dr. Goldenberg's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goldenberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →